Thursday, November 16, 2006

Leading Embryonic Stem Cell Research Firm Threatens

At issue: a company named Advanced Cell Technologies (ACT) claimed, in an article published in the journal Nature and in a press release dated August 23, 2006, that they had developed a technique that allowed the harvesting of embryonic stem cells from embryos without killing those embryos. The trouble is that ACT has flat-out lied about it. Nature has had to issue corrections that note that all of the embryos used in ACT's experiments died. So what is ACT doing? They're threatening to "monitor" LifeNews' future statements about ACT and its research. Evidently ACT's people don't have the gonadal fortitude to breathe or type the words legal action.

In fact, not only has Nature had to correct the record twice, but also--and most telling--Senators Arlen Specter (R-PA) and Tom Harkin (D-IA) have each criticized the lead researcher (Robert Lanza, PhD) for the shoddiness and sloppiness of his claims. "You've made our job a lot tougher," Specter has said--said job being an attempt to legislate for taxpayer funding of embryonic stem cell research.

And let's not forget that never once has anyone developed a treatment for any disease from embryonic stem cells--only from adult and umbilical cord blood stem cells, which we can have without killing the patient from whom we take them.


Links to this post:


<< Home